Literature DB >> 3001439

Cushing's syndrome: update of diagnosis and management.

P C Carpenter.   

Abstract

Although considerable advances have been made in the understanding of Cushing's syndrome in the recent past, many difficulties persist in the diagnosis and management of patients with hypercortisolism. Precision in the diagnosis of Cushing's syndrome and the differentiation of its various forms have gradually improved, but a substantial number of cases have laboratory or radiologic findings that can be misleading or at least difficult to interpret. Furthermore, other conditions may mimic Cushing's syndrome and add to the diagnostic difficulties. Surgical extirpation of primary adrenal lesions that cause the hypercortisolism or of the neoplasms responsible for the ectopic production of adrenocorticotropic hormone remains the treatment of choice for these problems. Currently, transsphenoidal surgical exploration is the treatment of choice for Cushing's disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3001439     DOI: 10.1016/s0025-6196(12)61398-6

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  7 in total

1.  Recurrent Cushing's disease with low adrenal androgen production.

Authors:  R J Louard; R A Gelfand
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

2.  Long-term follow-up on Cushing disease patient after transsphenoidal surgery.

Authors:  Insook Jeong; Moonyeon Oh; Ja Hye Kim; Ja Hyang Cho; Jin-Ho Choi; Han-Wook Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-09-30

3.  Adrenal adenoma with foci of oncocytes in a patient with pre-Cushing's syndrome.

Authors:  T Izumi; Y Kubota; I Sasagawa; K Itoh; T Nakada; K Kawai
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

4.  Cost-effectiveness and accuracy of the tests used in the differential diagnosis of Cushing's syndrome.

Authors:  J Puig; A Wägner; A Caballero; J Rodríguez-Espinosa; S M Webb
Journal:  Pituitary       Date:  1999       Impact factor: 4.107

5.  Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation.

Authors:  J R Tucci; K J Nowakowski; I M Jackson
Journal:  J Endocrinol Invest       Date:  1989-03       Impact factor: 4.256

6.  Corticotropin-releasing hormone test: improvement of the diagnostic accuracy of simultaneous and bilateral inferior petrosal sinus sampling in patients with Cushing syndrome.

Authors:  L Zarrilli; A Colao; B Merola; G La Tessa; R Spaziante; F S Tripodi; A Di Sarno; L A Marzano; G Lombardi
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

7.  Intraocular pressure and its correlation with midnight plasma cortisol level in Cushing's disease and other endogenous Cushing's syndrome.

Authors:  Priyadarshini Mishra; Alok Pratap Singh; Vikas Kanaujia; Rachna Agarwal; Prabhaker Mishra; Ashwani Guleria; Alka Tripathi
Journal:  Indian J Ophthalmol       Date:  2017-09       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.